139 related articles for article (PubMed ID: 12428842)
1. High-dose cytosine arabinoside-induced cutaneous reactions.
Cetkovská P; Pizinger K; Cetkovský P
J Eur Acad Dermatol Venereol; 2002 Sep; 16(5):481-5. PubMed ID: 12428842
[TBL] [Abstract][Full Text] [Related]
2. [Cytarabine and skin reactions in acute myeloid leukemia].
Grille S; Guadagna R; Boada M; Irigoin V; Stevenazzi M; Guillermo C; Díaz L
Medicina (B Aires); 2013; 73(6):535-8. PubMed ID: 24356262
[TBL] [Abstract][Full Text] [Related]
3. Post-remission therapy of adult acute myeloid leukemia: high dose cytosine-arabinoside versus other consolidation regimens.
Zeremski V; Savić A
Med Pregl; 2014; 67(3-4):83-90. PubMed ID: 24961049
[TBL] [Abstract][Full Text] [Related]
4. [Petechiae, suffusions and cytarabine-induced erythema in treatment of acute myeloid leukemia].
Taverna C; Jacky E; Sauter C
Schweiz Med Wochenschr; 1998 Jul; 128(27-28):1117. PubMed ID: 9691347
[No Abstract] [Full Text] [Related]
5. Cutaneous toxicity associated with high-dose cytosine arabinoside.
Richards C; Wujcik D
Oncol Nurs Forum; 1992 Sep; 19(8):1191-5. PubMed ID: 1408960
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy-induced acral erythema in leukemic patients: a report of 15 cases.
Demirçay Z; Gürbüz O; Alpdoğan TB; Yücelten D; Alpdoğan O; Kurtkaya O; Bayik M
Int J Dermatol; 1997 Aug; 36(8):593-8. PubMed ID: 9329890
[TBL] [Abstract][Full Text] [Related]
7. Florid skin rash in acute myeloid leukaemia.
Ammannagari N; Kaewpoowat Q; Ratanapo S; Patel A
BMJ Case Rep; 2013 Mar; 2013():. PubMed ID: 23542647
[No Abstract] [Full Text] [Related]
8. Cytosine arabinoside-induced vasculitis.
Ahmed I; Chen KR; Nakayama H; Gibson LE
Mayo Clin Proc; 1998 Mar; 73(3):239-42. PubMed ID: 9511781
[TBL] [Abstract][Full Text] [Related]
9. High Dose Cytosine Arabinoside in the consolidation of adult acute myeloid leukemia.
Rahman MH; Khan MA; Islam MS; Afrose S; Ara T
Mymensingh Med J; 2012 Apr; 21(2):213-9. PubMed ID: 22561761
[TBL] [Abstract][Full Text] [Related]
10. A randomized comparison of modified intermediate-dose Ara-C versus high-dose ara-c in post-remission therapy for acute myeloid leukemia.
Fukushima T; Urasaki Y; Yamaguchi M; Ueda M; Morinaga K; Haba T; Sugiyama T; Nakao S; Origasa H; Umehara H; Ueda T
Anticancer Res; 2012 Feb; 32(2):643-7. PubMed ID: 22287757
[TBL] [Abstract][Full Text] [Related]
11. Isolated Bilateral Ear and Scalp Rash After Cytarabine Therapy for Acute Myelogenous Leukemia: A Report and Literature Review.
Waseem H; Henriquez Felipe C; Hashmi AT; Ansar M; Batool A; Saverimuthu A; Kamholz SL
Am J Ther; 2019; 26(5):e653-e655. PubMed ID: 30418222
[No Abstract] [Full Text] [Related]
12. [Skin toxicity associated with bolus infusion of low-dose cytarabine].
Takeuchi M; Tanizawa A; Fukumoto Y; Kikawa Y; Mayumi M
Rinsho Ketsueki; 2001 Mar; 42(3):216-7. PubMed ID: 11345785
[TBL] [Abstract][Full Text] [Related]
13. Etoposide and mitoxantrone as a second cycle of consolidation therapy following high dose cytosine arabinoside and daunorubicin in patients with acute non-lymphocytic leukemia in remission: a pilot study.
Stein RS; Greer JP; Flexner JM; Goodman S; Wolff SN
Leuk Lymphoma; 1996 Sep; 23(1-2):93-8. PubMed ID: 9021690
[TBL] [Abstract][Full Text] [Related]
14. FLAG-IDA in the treatment of refractory/relapsed acute leukaemias: single centre study.
Hashmi KU; Khan B; Ahmed P; Raza S; Hussain I; Mahmood A; Iqbal H; Malik HS; Anwar M
J Pak Med Assoc; 2005 Jun; 55(6):234-8. PubMed ID: 16045091
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous side effects of medium dose methotrexate in children with acute lymphoblastic leukaemia.
van den Bos C; Bierings MB; Bruin MC; Rademaker CM; van Haselen CW; Révész T
Med Pediatr Oncol; 2000 Apr; 34(4):278-80. PubMed ID: 10742071
[No Abstract] [Full Text] [Related]
16. Low dose cytosine arabinoside in the treatment of acute non-lymphoblastic leukemia.
Insiripong S; Thaisamakr S
J Med Assoc Thai; 1996 Sep; 79(9):568-71. PubMed ID: 8996985
[TBL] [Abstract][Full Text] [Related]
17. Results of induction and consolidation treatment with intermediate and high-dose cytosine arabinoside and m-Amsa of patients with poor-risk acute myelogenous leukaemia.
Peters WG; Willemze R; Colly LP
Eur J Haematol; 1988 Mar; 40(3):198-204. PubMed ID: 3162718
[TBL] [Abstract][Full Text] [Related]
18. Toxic epidermal necrolysis after the use of high-dose cytosine arabinoside.
Ozkan A; Apak H; Celkan T; Yüksel L; Yildiz I
Pediatr Dermatol; 2001; 18(1):38-40. PubMed ID: 11207969
[TBL] [Abstract][Full Text] [Related]
19. Consolidation therapy for childhood acute lymphoblastic leukaemia: clinical and cellular pharmacology of cytosine arabinoside, epipodophyllotoxins and cyclophosphamide.
Estlin EJ; Yule SM; Lowis SP
Cancer Treat Rev; 2001 Dec; 27(6):339-50. PubMed ID: 11908927
[TBL] [Abstract][Full Text] [Related]
20. Cytosine-arabinoside induced bradycardia in patient with non-Hodgkin lymphoma: a case report.
Cil T; Kaplan MA; Altintas A; Pasa S; Isikdogan A
Leuk Lymphoma; 2007 Jun; 48(6):1247-9. PubMed ID: 17577797
[No Abstract] [Full Text] [Related]
[Next] [New Search]
